Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10844106rdf:typepubmed:Citationlld:pubmed
pubmed-article:10844106lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:10844106lifeskim:mentionsumls-concept:C0036866lld:lifeskim
pubmed-article:10844106lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10844106lifeskim:mentionsumls-concept:C0521329lld:lifeskim
pubmed-article:10844106lifeskim:mentionsumls-concept:C0027358lld:lifeskim
pubmed-article:10844106lifeskim:mentionsumls-concept:C1523909lld:lifeskim
pubmed-article:10844106pubmed:issue1lld:pubmed
pubmed-article:10844106pubmed:dateCreated2000-8-29lld:pubmed
pubmed-article:10844106pubmed:abstractTextPutative gender differences in opiate cardiovascular effects were evaluated in spinal rats. After a 4-h exposure to a single dose of morphine (30 mg/kg, i.v.), abstinence was precipitated by naloxone (0.03-3 mg/kg, i.v.). Morphine produced a long-lasting bradycardia and a transient increase in arterial pressure that was similar in both genders. Thereafter, blood pressure decreased both in males and females. Naloxone precipitated a similar dose-dependent heart rate increase in both sexes and a gender-dependent increase in blood pressure. This sex difference appeared in the shape of the response. Prazosin (0.2 mg/kg), prior to naloxone, reduced the pressor response in all animals, suggesting a similar participation of the noradrenergic system in both genders. The present results extend to acute dependence the notion of a sex-dependent differential effect of morphine. The need to consider gender as a factor when studying the effects of opioids is highlighted.lld:pubmed
pubmed-article:10844106pubmed:languageenglld:pubmed
pubmed-article:10844106pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844106pubmed:citationSubsetIMlld:pubmed
pubmed-article:10844106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844106pubmed:statusMEDLINElld:pubmed
pubmed-article:10844106pubmed:monthMaylld:pubmed
pubmed-article:10844106pubmed:issn0014-2999lld:pubmed
pubmed-article:10844106pubmed:authorpubmed-author:Rodríguez-Man...lld:pubmed
pubmed-article:10844106pubmed:authorpubmed-author:CruzS LSLlld:pubmed
pubmed-article:10844106pubmed:issnTypePrintlld:pubmed
pubmed-article:10844106pubmed:day26lld:pubmed
pubmed-article:10844106pubmed:volume397lld:pubmed
pubmed-article:10844106pubmed:ownerNLMlld:pubmed
pubmed-article:10844106pubmed:authorsCompleteYlld:pubmed
pubmed-article:10844106pubmed:pagination121-8lld:pubmed
pubmed-article:10844106pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:meshHeadingpubmed-meshheading:10844106...lld:pubmed
pubmed-article:10844106pubmed:year2000lld:pubmed
pubmed-article:10844106pubmed:articleTitleGender differences in the cardiovascular responses to morphine and naloxone in spinal rats.lld:pubmed
pubmed-article:10844106pubmed:affiliationDepartamento de Farmacología y Toxicología, Cinvestav, IPN, Apartado Postal 22026, 14000, D.F., Mexico City, Mexico. jcmolcruz@compuserve.com.mxlld:pubmed
pubmed-article:10844106pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10844106pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed